• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在阿根廷的项目背景下实施第二轮基于人乳头瘤病毒的宫颈癌筛查。

Implementation of second round of HPV-based screening for cervical cancer in programmatic contexts in Argentina.

作者信息

Barcena Barbeira Pilar, Paolino Melisa, Binder Fernando, Almonte Maribel, Baena Armando, Mazzadi Juan David, Arrossi Silvina

机构信息

Centro de Estudios de Estado y Sociedad Buenos Aires Argentina Centro de Estudios de Estado y Sociedad, Buenos Aires, Argentina.

Universidad de Buenos Aires Buenos Aires Argentina Universidad de Buenos Aires, Buenos Aires, Argentina.

出版信息

Rev Panam Salud Publica. 2025 Aug 28;49:e92. doi: 10.26633/RPSP.2025.92. eCollection 2025.

DOI:10.26633/RPSP.2025.92
PMID:40895372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12392847/
Abstract

OBJECTIVES

To evaluate implementation of the second round of human papillomavirus (HPV)-based cervical screening, introduced in Argentina in 2012-2014 through the Jujuy Demonstration Project for women 30 years and older, and describe the characteristics of women who adhere to the recommended five-year rescreening interval.

METHODS

A retrospective cohort study was conducted based on the data of two rounds of screening. All women aged 30 years or older who had been HPV-tested during the Jujuy Demonstration Project and had a negative result were included. The Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework was used to evaluate implementation. Multivariable regression was used to examine factors associated with adherence to rescreening.

RESULTS

Of 42 307 HPV-negative women, 47.9% ( = 20 285) were rescreened in the second round (Reach); 69.2% of health centers provided at least one HPV test at second-round screening (Adoption); and 13.3% ( = 5 639) of women were rescreened within the recommended five-year interval. Among the total rescreened, 9.3% ( = 1 888) were HPV-positive, of which 95.0% underwent triage Pap and 79.2% of the HPV-positive/abnormal Pap women had colposcopy. Considering women rescreened at five years, the second-round detection rate was 5.3/1 000 screened women. Rescreening at five years was significantly higher among women aged 30-44, with public health insurance, and those living in the provincial capital.

CONCLUSIONS

Rescreening of HPV-negative women faced challenges linked to its reduced reach, especially if we consider the recommended five-year interval. Our findings suggest that we need to devise specific strategies to increase second-round screening rates.

摘要

目的

评估2012 - 2014年通过胡胡伊示范项目在阿根廷为30岁及以上女性引入的第二轮基于人乳头瘤病毒(HPV)的宫颈癌筛查的实施情况,并描述坚持推荐的五年复查间隔的女性特征。

方法

基于两轮筛查数据进行回顾性队列研究。纳入所有在胡胡伊示范项目期间接受HPV检测且结果为阴性的30岁及以上女性。采用“覆盖、效果、采用、实施和维持”(RE - AIM)框架评估实施情况。使用多变量回归分析与复查依从性相关的因素。

结果

在42307名HPV阴性女性中,47.9%(n = 20285)在第二轮进行了复查(覆盖);69.2%的健康中心在第二轮筛查中至少提供了一次HPV检测(采用);13.3%(n = 5639)的女性在推荐的五年间隔内进行了复查。在所有复查者中,9.3%(n = 1888)为HPV阳性,其中95.0%接受了分流巴氏涂片检查,79.2%的HPV阳性/巴氏涂片异常女性进行了阴道镜检查。考虑到在五年时进行复查的女性,第二轮检测率为每1000名筛查女性中有5.3例。30 - 44岁、有公共医疗保险且居住在省会的女性在五年时的复查率显著更高。

结论

HPV阴性女性的复查面临与覆盖范围降低相关的挑战,特别是如果考虑推荐的五年间隔。我们的研究结果表明,我们需要制定具体策略以提高第二轮筛查率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb4a/12392847/cc41cc6ee492/rpsp-49-e92-Figure1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb4a/12392847/cc41cc6ee492/rpsp-49-e92-Figure1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb4a/12392847/cc41cc6ee492/rpsp-49-e92-Figure1.jpg

相似文献

1
Implementation of second round of HPV-based screening for cervical cancer in programmatic contexts in Argentina.在阿根廷的项目背景下实施第二轮基于人乳头瘤病毒的宫颈癌筛查。
Rev Panam Salud Publica. 2025 Aug 28;49:e92. doi: 10.26633/RPSP.2025.92. eCollection 2025.
2
[Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening].[卫生技术评估报告。液基细胞学在宫颈癌前病变筛查中的应用]
Epidemiol Prev. 2012 Sep-Oct;36(5 Suppl 2):e1-e33.
3
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.接种人乳头瘤病毒预防性疫苗以预防宫颈癌及其癌前病变。
Cochrane Database Syst Rev. 2018 May 9;5(5):CD009069. doi: 10.1002/14651858.CD009069.pub3.
4
The Utility of an Human Papillomavirus Genotype Assay for Cancer Screening in Self-Collected Urine and Vaginal Samples from Japanese Women.人乳头瘤病毒基因分型检测在日本女性自行采集的尿液和阴道样本癌症筛查中的效用
Gynecol Obstet Invest. 2025;90(2):143-152. doi: 10.1159/000541641. Epub 2024 Oct 7.
5
Cytology versus HPV testing for cervical cancer screening in the general population.普通人群宫颈癌筛查中细胞学检查与HPV检测的比较
Cochrane Database Syst Rev. 2017 Aug 10;8(8):CD008587. doi: 10.1002/14651858.CD008587.pub2.
6
Interventions targeted at women to encourage the uptake of cervical screening.针对女性的干预措施,以鼓励她们接受宫颈癌筛查。
Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3.
7
Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.人乳头瘤病毒检测与重复细胞学检查用于轻度宫颈细胞学病变的分流
Cochrane Database Syst Rev. 2013 Mar 28;2013(3):CD008054. doi: 10.1002/14651858.CD008054.pub2.
8
Delivering Guideline-Concordant Care for Patients With High-Risk HPV and Normal Cytologic Findings.为高危型人乳头瘤病毒(HPV)感染且细胞学检查结果正常的患者提供符合指南的护理。
JAMA Netw Open. 2025 Jan 2;8(1):e2454969. doi: 10.1001/jamanetworkopen.2024.54969.
9
Mailing human papillomavirus self-sampling kits to women under-screened for cervical cancer improved detection in cervical cancer screening in a general population study in Japan.向因宫颈癌筛查不足而未接受筛查的女性邮寄人乳头瘤病毒自我采样试剂盒,提高了日本普通人群宫颈癌筛查中的检出率。
BMC Public Health. 2023 Mar 11;23(1):473. doi: 10.1186/s12889-023-15402-7.
10
Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test.在未进行人乳头瘤病毒(HPV)检测的情况下,对于轻度宫颈细胞学异常,立即转诊至阴道镜检查与细胞学监测的比较
Cochrane Database Syst Rev. 2017 Jan 26;1(1):CD009836. doi: 10.1002/14651858.CD009836.pub2.

本文引用的文献

1
Performance of cervical cytology and HPV testing for primary cervical cancer screening in Latin America: an analysis within the ESTAMPA study.拉丁美洲原发性宫颈癌筛查中宫颈细胞学和HPV检测的性能:ESTAMPA研究中的一项分析
Lancet Reg Health Am. 2023 Sep 20;26:100593. doi: 10.1016/j.lana.2023.100593. eCollection 2023 Oct.
2
Quantification of impact of COVID-19 pandemic on cancer screening programmes - a case study from Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailand.量化 COVID-19 大流行对癌症筛查计划的影响 - 来自阿根廷、孟加拉国、哥伦比亚、摩洛哥、斯里兰卡和泰国的案例研究。
Elife. 2023 May 16;12:e86527. doi: 10.7554/eLife.86527.
3
Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis.
全球 202 个国家和地区的宫颈癌筛查规划和年龄别覆盖估计:综述和综合分析。
Lancet Glob Health. 2022 Aug;10(8):e1115-e1127. doi: 10.1016/S2214-109X(22)00241-8.
4
Effectiveness of an mHealth intervention to increase adherence to triage of HPV DNA positive women who have performed self-collection (the ATICA study): A hybrid type I cluster randomised effectiveness-implementation trial.一项移动健康干预措施对提高自行采集样本的HPV DNA阳性女性分诊依从性的效果(ATICA研究):一项混合型I类整群随机有效性-实施试验。
Lancet Reg Health Am. 2022 May;9. doi: 10.1016/j.lana.2022.100199. Epub 2022 Feb 13.
5
Extension of cervical screening intervals with primary human papillomavirus testing: observational study of English screening pilot data.以人乳头瘤病毒检测为基础的宫颈癌筛查间隔时间的延长:英国筛查试点数据的观察性研究。
BMJ. 2022 May 31;377:e068776. doi: 10.1136/bmj-2021-068776.
6
Human papillomavirus-based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer (HPV FOCAL) trial.基于人乳头瘤病毒(HPV)的筛查在延长的间隔时间内发现的宫颈癌前病变比细胞学检查少,这在 HPV 用于宫颈癌(HPV FOCAL)试验中得到了证实。
Int J Cancer. 2022 Sep 15;151(6):897-905. doi: 10.1002/ijc.34039. Epub 2022 May 10.
7
Cancer Screening During the COVID-19 Pandemic: A Systematic Review and Meta-analysis.2019冠状病毒病大流行期间的癌症筛查:系统评价与荟萃分析
Mayo Clin Proc Innov Qual Outcomes. 2021 Dec;5(6):1109-1117. doi: 10.1016/j.mayocpiqo.2021.10.003. Epub 2021 Oct 18.
8
Adherence to triage among women with HPV-positive self-collection: a study in a middle-low income population in Argentina.人乳头瘤病毒(HPV)自我采样阳性女性的分诊依从性:阿根廷中低收入人群的一项研究
Ecancermedicalscience. 2020 Nov 10;14:1138. doi: 10.3332/ecancer.2020.1138. eCollection 2020.
9
Primary HPV screening for cervical cancer: Results after two screening rounds in a regional screening program in Finland.宫颈癌的原发性人乳头瘤病毒筛查:芬兰一项区域筛查项目两轮筛查后的结果
Acta Obstet Gynecol Scand. 2021 Mar;100(3):403-409. doi: 10.1111/aogs.14021. Epub 2020 Oct 30.
10
Risk of CIN2 or more severe lesions after negative HPV-mRNA E6/E7 overexpression assay and after negative HPV-DNA test: Concurrent cohorts with a 5-year follow-up.HPV-mRNA E6/E7 过表达检测阴性和 HPV-DNA 检测阴性后 CIN2 或更严重病变的风险:5 年随访的同期队列。
Int J Cancer. 2020 Jun 1;146(11):3114-3123. doi: 10.1002/ijc.32695. Epub 2019 Oct 15.